TR200003735T2 - Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri - Google Patents

Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri

Info

Publication number
TR200003735T2
TR200003735T2 TR2000/03735T TR200003735T TR200003735T2 TR 200003735 T2 TR200003735 T2 TR 200003735T2 TR 2000/03735 T TR2000/03735 T TR 2000/03735T TR 200003735 T TR200003735 T TR 200003735T TR 200003735 T2 TR200003735 T2 TR 200003735T2
Authority
TR
Turkey
Prior art keywords
osteoporosis
prevention
treatment
disorders related
menopause syndrome
Prior art date
Application number
TR2000/03735T
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A filed Critical Sigma-Tau Healthscience S.P.A
Publication of TR200003735T2 publication Critical patent/TR200003735T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Bu bulus, karakterize edici aktif madde olarak propiyonil L-karnitin ve izoflavon genistein ihtiva eden ve osteoporoz ve/veya da menopoz sendromunun önlenmesi ve/ya da tedavisi için bir diyet takviyesi ya da bir ilaç seklini alabilen bir bilesim ile ilgilidir.
TR2000/03735T 1998-06-23 1999-06-17 Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri TR200003735T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa

Publications (1)

Publication Number Publication Date
TR200003735T2 true TR200003735T2 (tr) 2001-03-21

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03735T TR200003735T2 (tr) 1998-06-23 1999-06-17 Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri

Country Status (27)

Country Link
US (1) US6335038B1 (tr)
EP (1) EP1089742B1 (tr)
JP (1) JP4430233B2 (tr)
KR (1) KR20010071541A (tr)
CN (1) CN1306434A (tr)
AR (1) AR018924A1 (tr)
AT (1) ATE228367T1 (tr)
AU (1) AU755272B2 (tr)
BR (1) BR9911440A (tr)
CA (1) CA2334875C (tr)
DE (1) DE69904172T2 (tr)
DK (1) DK1089742T3 (tr)
EE (1) EE200000741A (tr)
ES (1) ES2188177T3 (tr)
HU (1) HU224957B1 (tr)
IL (1) IL140163A0 (tr)
IS (1) IS5764A (tr)
IT (1) IT1299191B1 (tr)
MA (1) MA26655A1 (tr)
NO (1) NO20006431L (tr)
NZ (1) NZ508877A (tr)
PL (1) PL192118B1 (tr)
PT (1) PT1089742E (tr)
SK (1) SK19292000A3 (tr)
TN (1) TNSN99132A1 (tr)
TR (1) TR200003735T2 (tr)
WO (1) WO1999066913A2 (tr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
AU2001245977A1 (en) * 2000-03-23 2001-10-03 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of menopause
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
IT1317079B1 (it) * 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
DE60221367T2 (de) * 2001-03-15 2008-04-03 Dsm Ip Assets B.V. ZUSAMMENSETZUNG ZUR PRÄVENTION VON OSTEOPOROSE bestehend aus EINER KOMBINATION AUS ISOFLAVONEN UND POLYUNGESÄTTIGTEN FETTSÄUREN
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
EP1474129A1 (en) * 2002-02-15 2004-11-10 N.V. Nutricia Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
BRPI0314066A8 (pt) * 2002-09-09 2017-12-12 Nestec Sa Método cosmético não-terapêutico para melhorar o turgor da pele em seres humanos ou animais, ou para prevenir ou restaurar alterações relacionadas ao envelhecimento em seres humanos ou animais, e uso de uma molécula, de um antioxidante, ou de uma combinação dos mesmos, para preparação de uma composição oralmente administrável
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
KR101254454B1 (ko) * 2003-05-27 2013-04-12 디에스엠 아이피 어셋츠 비.브이. 신규한 기능식품 조성물 및 그의 용도
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
AU2005211165B8 (en) * 2004-01-28 2011-07-14 Nestec S.A. Nutritional composition for improving skin condition and preventing skin diseases
KR100739280B1 (ko) 2004-02-03 2007-07-12 가부시끼가이샤 고또스기 운남 홍두삼 유래 이소탁시레시놀을 성분으로 하는골다공증 치료ㆍ예방약
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
ES2436181T3 (es) 2004-12-29 2013-12-27 Hill's Pet Nutrition Inc. Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales
JP2008526819A (ja) * 2005-01-10 2008-07-24 ホルモス メディカル リミテッド エストロゲン欠乏に関連する症状を予防または改善するための組成物を製造するためのリグナンの使用
PL1904044T3 (pl) * 2005-07-08 2013-08-30 Sigma Tau Ind Farmaceuti Zastosowanie kombinacji obejmującej L- karnitynę lub alkanoilo-L-karnitynę, rozpuszczalny w tłuszczach benzochinon oraz wielonienasycony kwas tłuszczowy omega-3 do wytwarzania suplementu diety lub leku do leczenia chorób rogówki
CN101262780B (zh) 2005-07-14 2013-04-24 希尔氏宠物营养品公司 一种延长动物生命的方法
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
EP1945195A2 (en) * 2005-10-14 2008-07-23 DSMIP Assets B.V. Novel use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases
JP2009514824A (ja) * 2005-11-02 2009-04-09 ネステク ソシエテ アノニム 雄の哺乳動物における体脂肪の蓄積を低減するためのイソフラボン組成物及びその使用方法
US20090221690A1 (en) * 2006-02-28 2009-09-03 Council Of Scientific And Industrial Research Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof
CN101389328B (zh) 2006-02-28 2013-04-24 雀巢技术公司 诱导骨生长和抑制骨流失的组合物和方法
WO2007116052A1 (en) * 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising dha and genistein for enhancing skin properties
WO2007116027A1 (en) * 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
JP2009534317A (ja) * 2006-04-12 2009-09-24 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚に対する抗老化効果を有する経口組成物
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
CA2736039C (en) * 2008-09-10 2016-06-07 Asahi Glass Co Ltd Novel prostaglandin i2 derivative
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
ES2593229T3 (es) * 2010-03-08 2016-12-07 Kaken Pharmaceutical Co., Ltd. Nuevo agonista de EP4
SG185692A1 (en) * 2010-06-16 2013-01-30 Sigma Tau Ind Farmaceuti Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
WO2012011572A1 (ja) * 2010-07-23 2012-01-26 国立大学法人大阪大学 拡張不全型心不全治療薬
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases

Also Published As

Publication number Publication date
ITRM980417A1 (it) 1999-12-23
PL192118B1 (pl) 2006-09-29
AU4390999A (en) 2000-01-10
JP4430233B2 (ja) 2010-03-10
DE69904172D1 (de) 2003-01-09
HUP0102879A2 (hu) 2002-03-28
HU224957B1 (en) 2006-04-28
EP1089742B1 (en) 2002-11-27
PL345030A1 (en) 2001-11-19
CN1306434A (zh) 2001-08-01
CA2334875C (en) 2009-05-12
PT1089742E (pt) 2003-04-30
IS5764A (is) 2000-12-08
EP1089742A2 (en) 2001-04-11
IT1299191B1 (it) 2000-02-29
CA2334875A1 (en) 1999-12-29
NZ508877A (en) 2002-09-27
EE200000741A (et) 2002-04-15
HUP0102879A3 (en) 2002-12-28
WO1999066913A3 (en) 2000-04-20
KR20010071541A (ko) 2001-07-28
DE69904172T2 (de) 2003-08-28
BR9911440A (pt) 2001-03-20
NO20006431D0 (no) 2000-12-15
TNSN99132A1 (fr) 2005-11-10
WO1999066913A2 (en) 1999-12-29
IL140163A0 (en) 2002-02-10
SK19292000A3 (sk) 2001-08-06
AR018924A1 (es) 2001-12-12
AU755272B2 (en) 2002-12-05
NO20006431L (no) 2001-02-22
ES2188177T3 (es) 2003-06-16
DK1089742T3 (da) 2003-03-24
JP2002518437A (ja) 2002-06-25
MA26655A1 (fr) 2004-12-20
ITRM980417A0 (it) 1998-06-23
US6335038B1 (en) 2002-01-01
ATE228367T1 (de) 2002-12-15

Similar Documents

Publication Publication Date Title
TR200003735T2 (tr) Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri
CY1120313T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες
BR9611802A (pt) Composições farmacêuticas
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
BR0015188A (pt) Composições farmacêuticas
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
PT1328268E (pt) Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
TR200200948T2 (tr) L-karnitin türevlerini ve ginkgo biloba özlerini içeren bileşim
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
TR200101344T2 (tr) Propionil L-karnitinden ve bir flavonoid'den oluşan antioksidan bileşim
PT1233788E (pt) Composicao para a prevencao e/ou tratamento de doencas devidas a metabolismo anomalo de lipidos compreendendo propionil l-carnitina e quitosana
ATE235483T1 (de) Neue chalchone
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
TR200200015T2 (tr) L-Karnitin ve türevleri ile crataegus ekstreleri içeren kardiyoaktif bileşim
BR0108823A (pt) Composição farmacêutica para o tratamento da doença cerebrovascular cognitiva
UY27406A1 (es) Derivados de 2h-1-benzopirano, procesos para su preparación y composiciones farmacéuticas que los contienen
TH57976B (th) ส่วนประกอบอีพลีรีโนน
TH57976A (th) ส่วนประกอบอีพลีรีโนน